aderolio 0,75 mg tabletki
sandoz gmbh - everolimusum - tabletki - 0,75 mg
aderolio 1 mg tabletki
sandoz gmbh - everolimusum - tabletki - 1 mg
rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - zapalenie stawów, reumatoidalne - leki immunosupresyjne - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
welbox 150 mg tabletki o zmodyfikowanym uwalnianiu
+pharma arzneimittel gmbh - bupropioni hydrochloridum - tabletki o zmodyfikowanym uwalnianiu - 150 mg
doppelsil max 50 mg tabletki do rozgryzania i żucia
doppelherz pharma gmbh - sildenafilum - tabletki do rozgryzania i żucia - 50 mg
doppelsil 25 mg tabletki do rozgryzania i żucia
doppelherz pharma gmbh - sildenafilum - tabletki do rozgryzania i żucia - 25 mg
bilargena 20 mg tabletki
sandoz gmbh - bilastyna - tabletki - 20 mg
metoclopramide hameln 5 mg/ml roztwór do wstrzykiwań
hameln pharma gmbh - metoklopramidu chlorowodorek jednowodny - roztwór do wstrzykiwań - 5 mg/ml
rifen 100 mg/ml roztwór do wstrzykiwań dla koni, bydła i świń 100 mg/ ml roztwór do wstrzykiwań
vetviva richter gmbh - ketoprofenum - roztwór do wstrzykiwań - 100 mg/ ml - bydło; koń; świnia
valerianaheel krople doustne, roztwór
biologische heilmittel heel gmbh - krople doustne, roztwór